The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ
This podcast describes the recent experience of single agent rituximab as management for newly diagn
The mature results of a randomized comparison of S-1 versus observation in Japanese patients who hav
Children treated for medulloblastoma using reduced dose craniospinal radiation with local tumor bed
The meta-analysis by Houssami and colleagues notes no recurrence benefit of breast MRI, and adds to
Reflections on a new report describing the successful therapy of lymphomas using adoptively transfer
This podcast provides observations and commentary on the study by Payne and colleagues entitled ‘Pha
An increased-dosage radioimmunotherapy for upfront treatment of follicular lymphoma achieves excelle
This podcast describes the recent experience of high dose cytarabine induction in patients with acut
MRI done prior to surgery can be useful in determining the long-term outcomes after surgical resecti
The study by Kapoor et al supports reporting outcome of clinical trials using more stringent uniform
This podcast reviews outcomes for elderly patients with HODGKIN lymphoma at diagnosis and at the tim
Sentinel node biopsy should be performed for melanomas greater than or equal to 0.75mm in thickness
This podcast discusses Neben and colleagues' paper on FISH findings and smoldering myeloma.
This JCO Podcast comments on the JCO article, "Interim Cosmetic and Toxicity Results From Rapid: A R
Before we can use MRD as a guide of post-remission therapy in AML, we have to standardize our method
ACRIN 6668/RTOG 0235 demonstrates that a post chemoradiotherapy PET scan for locoregionally advanced
Added to the complexity of the widening variety of vaccines that are in current clinical trial for h
Lenalidomide is a promising agent for the treatment of mantle cell lymphoma.
The results of CALGB 50202 reported by Rubenstein and colleagues demonstrate the feasibility, safety
This podcast reviews the biology and treatment of relapse of acute myeloid leukemia following hemato
